Global Fertility Enhancing Treatment Market Growth (Status and Outlook) 2025-2031

Global Fertility Enhancing Treatment Market Growth (Status and Outlook) 2025-2031

The global Fertility Enhancing Treatment market size is predicted to grow from US$ 5455 million in 2025 to US$ 7930 million in 2031; it is expected to grow at a CAGR of 6.4% from 2025 to 2031.

Infertility Drugs are drugs which enhance reproductive fertility. For women, Infertility Drugs is used to stimulate follicle development of the ovary. Agents that enhance ovarian activity can be classified as either Gonadotropin releasing hormone, Estrogen antagonists or Gonadotropins.

Global Fertility Enhancing Treatment key players include Merck, Ferring, MSD, LIVZON, Abbott, etc. Global top five manufacturers hold a share about 60%.

North America is the largest market, with a share over 30%, followed by China, and Europe, both have a share about 40 percent.

In terms of product, Fertility Drugs for Women is the largest segment, with a share over 85%. And in terms of application, the largest application is Drug Stores, followed by Hospitals, Online, etc.

LPI (LP Information)' newest research report, the “Fertility Enhancing Treatment Industry Forecast” looks at past sales and reviews total world Fertility Enhancing Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Fertility Enhancing Treatment sales for 2025 through 2031. With Fertility Enhancing Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Fertility Enhancing Treatment industry.

This Insight Report provides a comprehensive analysis of the global Fertility Enhancing Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Fertility Enhancing Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Fertility Enhancing Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Fertility Enhancing Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Fertility Enhancing Treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Fertility Enhancing Treatment market by product type, application, key players and key regions and countries.

Segmentation by Type:
Fertility Drugs for Women
Fertility Drugs for Men
OTC Conception Gels/Lubricants

Segmentation by Application:
Hospitals
Drug Stores
Online

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Merck
Ferring
MSD
LIVZON
Abbott
Bayer Zydus Pharma
Church＆Dwight
SASMAR
BioFilm,Inc
FAIRHAVEN HEALTH
The YES YES Company

Please note: The report will take approximately 2 business days to prepare and deliver.